Image credit: Nushin Rashidian

FDA Launches Biggest Cannabis Data Collection Plan Yet

The Food and Drug Administration has been on a march to collect cannabinoid-related data. The “Cannabis-Derived Products Data Acceleration Plan” released this month is its most robust effort.

CBD
Congress

SAFE Banking Scrapped from NDAA Despite Major Push

Banking groups and lawmakers rallied behind legislation to allow banks to more freely work with cannabis businesses. Ultimately, it was stripped.

CBD

FDA: The Cannabis Regulatory Landscape is “Complex”

A policy coordinator with the FDA’s Cannabis Product Committee spoke about CBD during a Food and Drug Law Institute event focused on cannabis.